Focused on cellular health research, the company develops and commercializes nicotinamide riboside (NR), a form of vitamin B3 marketed as an NAD+ precursor used in dietary supplements and clinical research. Its Niagen ingredient and Tru Niagen consumer brand generate revenue through ingredient licen...
1 member of Congress has disclosed 1 trade in ChromaDex Diagnostics Inc (CDXC), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-06-04 | Chris Collins | sell | $1K – $15K |